In our study, urinary PAH metabolites, identified as harmful substances, were associated with a decrease in Apo A1 and an increase in Apo B and LDL-C, suggesting that PAH metabolites may elevate the risk of cardiovascular disease. This evidence concerns the gene APOB and cardiovascular disorder.